Literature DB >> 26085717

Identification of XRCC1 Arg399Gln and XRCC3 Thr241Met Polymorphisms in a Turkish Population and Their Association with the Risk of Chronic Lymphocytic Leukemia.

Pelin Mutlu1, Mualla Pınar Elçi2, Murat Yıldırım3, Oral Nevruz3, Ahmet Türker Çetin3, Ferit Avcu4.   

Abstract

DNA repair systems are essential for cellular functions. Defects due to sequence variations in DNA repair genes can lead severe failure of cell functions and causing many cancer types including leukemia. The aim of this study was to investigate the relationship between XRCC1 Arg399Gln and XRCC3 Thr241Met polymorphisms and susceptibility to chronic lymphocytic leukemia (CLL) in Turkish patients. In addition, genotype distribution of these polymorphisms was compared with other populations. The frequencies of Arg399Gln and Thr241Met single nucleotide polymorphisms were studied in 25 CLL patients and 30 healthy individuals. Single nucleotide polymorphisms were genotyped by PCR-RFLP method. The genotype and allele frequencies of Arg399Gln and Thr241Met polymorphisms were not statistically different between the CLL patients and control group. The allelic frequency similarities were found between Turkish and Brazilian populations for Arg399Gln polymorphism. On the other hand, similarities were found between Turkish and other Caucasian populations for Thr241Met polymorphism. Marked differences were observed between American African versus Turkish and Chinese versus Turkish populations for Arg399Gln and Thr241Met polymorphisms respectively. These results indicate that Arg399Gln and Thr241Met polymorphisms were not associated with the development of CLL in Turkish population and ethnic differences is one of the most important factor for allele frequency differences.

Entities:  

Keywords:  Chronic lymphocytic leukemia; SNP; XRCC1; XRCC3

Year:  2014        PMID: 26085717      PMCID: PMC4465508          DOI: 10.1007/s12288-014-0482-1

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  34 in total

1.  Genetic polymorphisms of XRCC1 and risk of gastric cancer.

Authors:  Seong-Gene Lee; Byungsik Kim; Jaewon Choi; Changhoon Kim; Inchul Lee; Kyuyoung Song
Journal:  Cancer Lett       Date:  2002-12-10       Impact factor: 8.679

2.  Allelic variants of XRCC1 and XRCC3 repair genes and susceptibility of oral cancer in Brazilian patients.

Authors:  Mariana Bisarro Dos Reis; Roberta Losi-Guembarovski; Enilze Maria de Souza Fonseca Ribeiro; Iglenir João Cavalli; Maria Celeste Morita; Gyl Henrique Albrecht Ramos; Benedito Valdecir de Oliveira; Lauro Toyoshi Mizuno; Silvia Regina Rogatto; Ilce Mara de Syllos Cólus
Journal:  J Oral Pathol Med       Date:  2012-07-09       Impact factor: 4.253

3.  Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes.

Authors:  M T Voso; E Fabiani; F D'Alo'; F Guidi; A Di Ruscio; S Sica; L Pagano; M Greco; S Hohaus; G Leone
Journal:  Ann Oncol       Date:  2007-09       Impact factor: 32.976

4.  Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia.

Authors:  David Oscier; Claire Dearden; Efrem Eren; Efrem Erem; Christopher Fegan; George Follows; Peter Hillmen; Tim Illidge; Estella Matutes; Don W Milligan; Andrew Pettitt; Anna Schuh; Jennifer Wimperis
Journal:  Br J Haematol       Date:  2012-10-11       Impact factor: 6.998

5.  XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis.

Authors:  Rensheng Wang; Xueying Hu; Yang Zhou; Qiming Feng; Li Su; Jianxiong Long; Bo Wei
Journal:  Leuk Lymphoma       Date:  2012-07-09

6.  Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia.

Authors:  Maja Krajinovic; Damian Labuda; Geraldine Mathonnet; Marcin Labuda; Albert Moghrabi; Josette Champagne; Daniel Sinnett
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

7.  XRCC1 polymorphisms and haplotypes in Mexican patients with acute lymphoblastic leukemia.

Authors:  J P Meza-Espinoza; V Peralta-Leal; M Gutierrez-Angulo; N Macias-Gomez; M L Ayala-Madrigal; P Barros-Nuñez; J Duran-Gonzalez; E Leal-Ugarte
Journal:  Genet Mol Res       Date:  2009-12-01

8.  Gene polymorphism of XRCC1 Arg399Gln and cervical carcinoma susceptibility in Asians: a meta-analysis based on 1,759 cases and 2,497 controls.

Authors:  Yi-Ting Liu; Jing-Pu Shi; Ling-Yu Fu; Bo Zhou; Hai-Long Wang; Xiao-Mei Wu
Journal:  Asian Pac J Cancer Prev       Date:  2013

9.  The genotype distribution of the XRCC1, XRCC3, and XPD DNA repair genes and their role for the development of acute myeloblastic leukemia.

Authors:  Amani Sorour; Mona Wagdy Ayad; Hala Kassem
Journal:  Genet Test Mol Biomarkers       Date:  2013-02-11

10.  XRCC1 Arg194Trp polymorphism, risk of nonmelanoma skin cancer and extramammary Paget's disease in a Japanese population.

Authors:  Koji Chiyomaru; Tohru Nagano; Chikako Nishigori
Journal:  Arch Dermatol Res       Date:  2012-05-26       Impact factor: 3.017

View more
  1 in total

1.  Ethnicity-stratified analysis of the association between XRCC3 Thr241Met polymorphism and leukemia: an updated meta-analysis.

Authors:  Zhengjun Xie; Wei Peng; Qiuhua Li; Wei Cheng; Xin Zhao
Journal:  BMC Med Genomics       Date:  2021-09-18       Impact factor: 3.063

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.